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Globozoospermia is a rare (incidence !0.1% in male infertile patients) form of teratozoospermia, mainly characterized
by round-headed spermatozoa that lack an acrosome. It originates from a disturbed spermiogenesis, which is expected
to be induced by a genetic factor. Several family cases and recessive mouse models with the same phenotype support
this expectation. In this study, we present a consanguineous family with three affected brothers, in whom we have
identified a homozygous mutation in the spermatogenesis-specific gene SPATA16. This is the first example of a nonsyn-
dromic male infertility condition in humans caused by an autosomal gene defect, and it could also mean that the
identification of other partners like SPATA16 could elucidate acrosome formation.
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Approximately 15% of couples are confronted with the
inability to conceive after 2 years of unprotected inter-
course.1 In about half of these cases, infertility is due to
the inability of the male partner to produce spermatozoa
of sufficient number (oligozoospermia), adequate motility
(asthenozoospermia), or normal morphology (teratozoo-
spermia) or to combinations of these defects. Globozoo-
spermia (MIM 102530) is a rare but severe teratozoosper-
mia, characterized by ejaculates consisting completely of
round-headed spermatozoa that lack an acrosome or, in
partial globozoospermia, containing a variable proportion
(20%-90%) of acrosomeless spermatozoa.2–4 Men that are
affected with total globozoospermia are infertile, and even
the application of intracytoplasmic sperm injection (ICSI)
has met with disappointingly low success rates.2 Globo-
zoospermia originates from a disturbed spermiogenesis,
and, although the underlying cause is still unknown, a
genetic contribution appears to be supported by several
familial case reports5–7 and by three recessive mouse
models involving CSNK2A2 (MIM 115442), HRB (MIM
600862), and GOPC (MIM 606845).8–10 However, no caus-
ative gene mutations have been identified in these ortho-
logues or any other human genes to date.11,12 We describe
a family with three affected brothers, in whom we have
identified a homozygous mutation in the spermatogene-
sis-specific gene SPATA16 (MIM 609856). To our knowl-
edge, this is the first example of a nonsyndromic male
infertility condition in humans caused by a single gene
defect.
We investigated an Ashkenazi Jewish family with six
brothers (three affected and three healthy) and four sisters
(fig. 1D) that was identified at the Centre for Reproductive
Medicine of the Dutch-Speaking Brussels Free University.
The three unaffected brothers fathered seven, six, and five
children, respectively, but the three affected brothers were
childless and presented with a fertility disorder due to
oligoasthenoteratozoospermia, showing the characteris-
tics of total globozoospermia, such as roundheadedness
and acrosomelessness, as shown by acrosin (MIM 102480)
staining in figure 1A. No known consanguinity was re-
ported, although the family belonged to an isolated Jewish
population. A normal karyotype and no Y-chromosome
microdeletion were found. In two brothers, ICSI was per-
formed, but fertilization was poor, and no pregnancy
occurred.
We performed a genomewide scan analysis of all six
brothers, using a 10K SNP array (Affymetrix GeneChip).
Regions of homozygosity were defined by the presence of
125 consecutive homozygous SNPs. Large regions of ho-
mozygosity were observed in all six individuals (tables 1
and 2), indicating consanguinity in the second or third
degree in the family. Therefore, we considered this family
to be consanguineous and expected the pathology to be
autosomal recessive. We identified a unique region of hap-
lotypic identical homozygosity shared by all affected
brothers, in which the healthy brothers were heterozy-
gous. The smallest region of overlap spanned 17 Mb of
chromosome 3q26 (167054711–184087390). This region
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Figure 1. Family with globozoospermia and a mutation in the SPATA16 gene. A, Sperm morphology. Fluorescent acrosin (green) staining
(with fluorescein) of acrosomes and 4′,6-diamidino-2-phenylindole (blue) staining of nuclei. On the left is a sample from a fertile
control, in which the most important content of the acrosome (acrosin) is clearly and abundantly present; on the right is a sample
from a patient. Sperm morphology and acrosome structures are severely disrupted in patient cells. Remnants of acrosin staining were
observed for some deformed sperm cells, but most signals represent nonspecific acrosin staining in the leukocytes. B, Chromatograms
of the mutation. Shown are the sequences from a control sample, the heterozygous father, and one of the patients. C, The NciI recognition
site (5′-CCCGG-3′) is lost because of the GrA mutation at the last nucleotide of exon 4. (The HpaII recognition site is not shown but
overlaps at 5′-CCGG-3′). This mutation predicts a R283Q amino acid substitution, as well as the disruption of the 5′ splice site of intron
4. D, Pedigree of the Ashkenazi Jewish family in this study. The order of the 10 siblings is arbitrary. The segregation of the mutation
was studied by NciI digestion of a PCR amplification of exon 4 and its flanking sequences. The first lane is the marker lane. As asterisk
(*) indicates tested individuals. The two parents and two siblings are heterozygous for the mutation. The three affected males are
homozygous, and one unaffected male and a control (C) are not carriers of the mutation.
Figure 2. Sequence alignment of SPATA16
contains ∼50 known genes in the UCSC Genome Browser.
We selected the SPATA16 gene (spermatogenesis-associ-
ated 16, also known as “NYD-SP12”) as the most plausible
candidate gene, because recent studies showed that
SPATA16 is specifically expressed in human testis and that
the mouse ortholog is primarily expressed in the sper-
matocyte and spermatids.13 Localization in the Golgi ap-
paratus and the shift with Golgi vesicles to the acrosome
was observed in round and elongated spermatids by use
of a SPATA19-GTP (green fluorescent protein) fusion pro-
tein, strongly suggesting a role for the SPATA16 protein
in acrosome formation during spermiogenesis.14 SPATA16
is composed of 11 exons encoding a highly conserved
protein of 65 kDa (569 aa), which contains a tetratrico-
peptide repeat (TPR [MIM 602259]) domain. Sequence
alignment (by use of ClustalW 1.81 [SDSC Biology Work-
bench]) (fig. 2) shows that SPATA16 is highly conserved
across mammals, exhibiting an identity rate varying from
77% (mouse) to 96% (chimpanzee) (NCBI Blast) (table 3).
The conservation is even higher (92% and 98% in mouse
and chimpanzee, respectively) for the TPR domain, a
protein-protein interaction domain commonly but exclu-
sively found in cochaperone proteins.15
Sequence analysis of one of the affected sons revealed
a homozygous sequence variation in exon 4 (c.848GrA),
which disrupts a NciI or an HpaII recognition site (fig. 1C).
Restriction-enzyme analysis revealed that the three af-
fected brothers are homozygous and that the two parents
and two healthy brothers are heterozygous for the mu-
tation. The third unaffected brother appeared to be ho-
mozygous for the wild-type sequence (fig. 1D). The
c.848GrA nucleotide variation is not known in any SNP
database and was not identified in 231 controls, including
151 random controls of both sexes and 80 fertile males.
The mutation predicts an amino acid change of a highly
conserved residue (p.R283Q) located at the C-terminal end
of the highly conserved TPR domain. In addition, the
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Table 1. Results of the SNP Array for the Three Affected
Brothers
Chromosome 3
Position SNP
Genotype Call in Sibling
1 2 3
165727121 SNP_A-1508753 AA AA AA
167054711 SNP_A-1512676 AB AB AB
167631594 SNP_A-1508627 AA AA AA
167801377 SNP_A-1519252 AA AA AA
169050879 SNP_A-1511126 BB BB BB
169140975 SNP_A-1509483 AA AA AA
169748882 SNP_A-1518417 BB BB BB
170222552 SNP_A-1518965 BB BB BB
170229669 SNP_A-1509719 BB BB BB
170266790 SNP_A-1519387 BB BB BB
170341708 SNP_A-1513150 BB BB BB
170440150 SNP_A-1513458 AA AA AA
170815817 SNP_A-1516975 AA AA AA
171062673 SNP_A-1514614 No Call AA No Call
171141972 SNP_A-1508020 BB BB BB
172368188 SNP_A-1510308 AA AA AA
172643136 SNP_A-1517656 BB BB BB
172771949 SNP_A-1509479 AA AA AA
172933454 SNP_A-1509435 AA AA AA
172933529 SNP_A-1509382 BB BB BB
173575998 SNP_A-1516388 BB BB BB
173580444 SNP_A-1514288 BB BB BB
173580729 SNP_A-1514241 AA AA AA
174671975 SNP_A-1507368 AA AA AA
175782878 SNP_A-1508795 BB BB BB
176537318 SNP_A-1511779 AA AA AA
176610712 SNP_A-1509801 BB BB BB
176827123 SNP_A-1511813 AA AA AA
177333023 SNP_A-1517824 AA AA AA
177621541 SNP_A-1518682 BB BB BB
177708137 SNP_A-1510834 AA AA AA
177723240 SNP_A-1516780 BB BB BB
178105620 SNP_A-1516425 AA AA AA
178105781 SNP_A-1515959 No Call BB No Call
179324469 SNP_A-1517000 No Call AA No Call
179597123 SNP_A-1516215 AA AA AA
179597352 SNP_A-1516746 AA AA AA
179636158 SNP_A-1512810 BB BB BB
179706441 SNP_A-1510950 BB BB BB
179839122 SNP_A-1514173 BB BB BB
180413909 SNP_A-1511671 AA AA AA
180729255 SNP_A-1508156 BB BB BB
181028753 SNP_A-1512457 BB BB BB
181180943 SNP_A-1507868 BB BB BB
181251555 SNP_A-1512336 AA AA AA
181298402 SNP_A-1513747 AA AA AA
181506449 SNP_A-1517808 BB BB BB
181552274 SNP_A-1509494 BB BB BB
NOTE.—Several large areas of shared haplotype were identified, indi-
cating consanguinity. The area of shared haplotype on which we con-
centrated is shown.
c.848GrA mutation affects the last nucleotide of exon 4
(fig. 1C) and, therefore, may disrupt the 5′ splice site of
intron 4. Three different splice-site prediction models pre-
dicted that the mutation disrupts this splice site (table 4).
Unfortunately, the SPATA16 protein presents a testis-
restricted expression, and we were not allowed to use fresh
sperm cells or to perform a biopsy in these religious pa-
tients to verify the predicted aberrant splicing in vivo.
Therefore, minigene constructs were made that consisted
of two constitutive b-globin exons surrounding a 420-bp
fragment containing either the wild-type or the mutated
form of exon 4 and the flanking intronic sequences of
SPATA16. These minigene constructs were transfected into
COS1 or HeLa cells, and transcripts were analyzed by RT-
PCR 24 h after the transfection (fig. 3A). As shown in figure
3B, wild-type exon 4 is invariably included in the final
mRNA, as confirmed by the sequencing of the PCR prod-
uct. In sharp contrast, the mutated exon gives rise to two
aberrant splicing forms, as shown by cloning and sequenc-
ing of these PCR products. The most prominent, larger
product is the result of the use of a splice site situated in
the b-globin intron used for the minigene construct. The
weaker, smaller product corresponds to the use of a cryptic
splice site situated 18 bp upstream of the normal splice
site. These aspecific products are likely the result of the
very short intron sequences in the minigene construct.
Such products are often seen in exon-trapping experi-
ments in the absence of a bona fide splice site and are
indicative of the occurrence of exon skipping due to the
mutation.16,17 Importantly, we did not detect any tran-
script containing the correct junctions from the mutated
exon 4, indicating that the mutation hinders normal
splicing.
The first and critical step of exon inclusion is the bind-
ing of the U1 small nuclear ribonucleoprotein (SnRNP)
splicing factor to the 5′ splice sites.18 To confirm that the
mutated SPATA16 exon 4 is not recognized by the splicing
machinery, we checked its binding to the U1 SnRNP by
psoralen-mediated UV crosslinking. Whereas binding of
U1 SnRNP to wild-type DNA was readily detected, this was
not observed when DNA carrying the c.848GrA mutation
was used as template (fig. 3C). The identity of the U1
SnRNP was confirmed by RNAse H treatment by use of an
oligodeoxynucleotide complementary to positions 1–15
of U1 SnRNA.19 Therefore, the results of the bioinformatic
prediction, the minigene, and the U1 binding strongly
suggest that the c.848GrA mutation leads to inappropri-
ate splicing of exon 4 and, therefore, the disruption of the
TPR domain.
SPATA16 was also analyzed in 29 patients with globo-
zoospermia, including 6 familial cases involving 14 pa-
tients. Of the 29 patients, 12 presented with total globo-
zoospermia, and 17 with partial globozoospermia. None
of them presented with any variation in the SPATA16 se-
quence, with the exception of three known polymor-
phisms and two point mutations that did not segregate
with the disease (table 5).
Table 2. Areas of Shared Haplotype and Shared Homozygosity
Shared Haplotype Shared Homozygosity
Chromosome
and Start
Position
Stop
Position
Fragment
Length
(bp)
No. of
SNPsa
Start
Position
Stop
Position
Fragment
Length
(bp)
No.
of
SNPsa
1:
33955677 36556426 2,600,749 15
117399167 119296010 1,896,843 11 117866019 119296010 1,429,991 6
151489481 156376556 4,887,075 11 151489481 156376556 4,887,075 11
160643582 162290883 1,647,301 14
194965564 198362174 3,396,610 10
2:
19716714 34386124 14,669,410 55
54483803 57217291 2,733,488 14
59155900 65801963 6,646,063 11
65801963 107509848 41,707,885 91
113469814 115959977 2,490,163 12
212719583 215032622 2,313,039 10
224103332 226044921 1,941,589 16
234216839 239151790 4,934,951 14 234719101 239151790 4,432,689 8
3:
653347 3558063 2,904,716 12
100634082 103786422 3,152,340 10
113839242 127152417 13,313,175 48
165655532 184087390 18,431,858 49 167054711 184087390 17,032,679 47
184087390 190712906 6,625,516 26
4:
173190930 176925273 3,734,343 10 173530324 176925273 3,394,949 8
181334851 191091333 9,756,482 48
5:
120723042 122283900 1,560,858 11 121110284 122283900 1,173,616 7
134671015 139500740 4,829,725 15
6:
28766533 31094058 2,327,525 10 29479394 31094058 1,614,664 6
46333713 47986997 1,653,284 14 46824038 47986997 1,162,959 5
96879221 102207593 5,328,372 12
105174572 108446020 3,271,448 10
108446020 52383480 43,937,460 169
7:
77627148 131407468 53,780,320 169
8:
53838124 57959516 4,121,392 15
72728798 76200122 3,471,324 10
9:
507715 13460671 12,952,956 85 12445236 13460671 1,015,435 6
72760108 75532057 2,771,949 10 73265909 75532057 2,266,148 7
75532057 90138831 14,606,774 56
10:
63884288 66164664 2,280,376 10
66164664 68113302 1,948,638 10
91501439 105835217 14,333,778 47
14:
19490525 22620727 3,130,202 20
31508337 33265230 1,756,893 10
36021565 37647284 1,625,719 10
15:
21490270 23325412 1,835,142 13
23325412 59077153 35,751,741 127
79723090 84387340 4,664,250 12
16:
22705353 50026393 27,321,040 24
17:
28942222 34693022 5,750,800 10 29183029 34693022 5,509,993 9
66657008 72151125 5,494,117 10
18:
63746898 66906214 3,159,316 13 64766169 66906214 2,140,045 9
20:
38790879 43185196 4,394,317 10
21:
18764912 21113081 2,348,169 11 18764912 21113081 2,348,169 11
29925652 31842275 1,916,623 12
36234195 37974748 1,740,553 10 36447405 37974748 1,527,343 7
NOTE.—In the left part of the table, a selection of the areas of shared haplotype (those with (19 SNPs) is displayed. In
the right part of the table, the regions of shared homozygosity (with 14 SNPs) that lie within are shown.
a Number of SNPs that form the area of shared haplotype or homozygosity.
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Figure 3. Mutated donor splice site of SPATA16 intron 4 and U1 SnRNP binding to wild-type (WT) and mutant (MT) donor splice sites.
A, Overview of the used prediction sites. B, Minigene constructs used to test the splicing of exon 4. T- p construct without exon;
T-RT p construct without exon in RT-PCR. C, Gel showing that wild-type exon 4 is invariably included in the final mRNA. In sharp
contrast, the mutant exon gives rise to two aberrant splicing forms. M p marker lane. D, U1 SnRNP binding analyzed by psoralen-
mediated UV-crosslinking experiments, revealing that mutant exon 4 is not recognized by the splicing machinery, whereas wild-type
exon 4 is clearly recognized. The identity of the U1 SnRNP was confirmed by RNAse H treatment with use of an oligodeoxynucleotide
complementary to nucleotide positions 1–15 of U1 SnRNA.
This is, to our knowledge, the first description of a gene
involved in the pathogenesis of human globozoospermia.
The data strongly suggest that the identified homozygous
mutation in SPATA16 causes globozoospermia in three of
six brothers in the family studied, which allows us to state
that globozoospermia can be a genetic trait with an au-
tosomal recessive mode of transmission. The SPATA16 pro-
tein localizes to the Golgi apparatus and to the proacro-
somic vesicles that are transported to the acrosome in
round and elongated spermatids during spermiogenesis.
Our observations support the hypothesis of a crucial role
for SPATA16 in acrosome formation.14 The strongest pro-
tein conservation is seen in the TPR domain, which is
disrupted in these cases of globozoospermia. The TPR do-
main is known to mediate protein-protein interactions
and assembly of multiprotein complexes. Study of the x-
ray structure revealed that the TPR domain adopts a helix-
turn-helix arrangement, with the ability to associate with
818 The American Journal of Human Genetics Volume 81 October 2007 www.ajhg.org
Table 3. Identity Rates among Species for the SPATA16 Sequence and the TPR Domain
of the Protein
Species
Identity with Human
(%)
Positivesa
(%)
Gapsb
(%)
SPATA16
TPR
Domain SPATA16
TPR
Domain SPATA16
TPR
Domain
Homo sapiens 100 100 100 100 0 0
Bos taurus 87 94 92 97 0 0
Canis familiaris 83 97 89 97 0 0
Macaca fascicularis 95 97 97 97 0 0
Mus musculus isoform 1 77 92 86 96 0 0
M. musculus isoform 2 78 92 87 96 0 0
Pan troglodytes 96 98 98 98 0 0
Rattus norvegicus 80 93 87 96 0 0
a Amino acid positive-match score.
b Space introduced into an alignment to compensate for insertions and deletions in one sequence
relative to another. In our search, the gaps did not exceed 0.5%.
Table 4. Splice-Site Predictions from Three Web Sites
Web Sitea
Odds Ratio for Sequence
Wild Type Mutant
NetGene2 Server .80 !.50
SpliceSiteFinder .805 .681
Splice Site Prediction by Neural Network .97 !.40
a See the Web Resources for URLs.
other a-helical structures. A possible interacting protein
may be from the gene GOPC, a Golgi-associated protein
containing coiled-coil motif a-helices,10 or from the HIV-
1 rev binding protein gene (HRB), which also localizes to
the Golgi complex.9 Both these genes are involved in the
pathogenesis of globozoospermia in mouse models. Fi-
nally, it is worth noting that SPATA16 contains six casein
kinase II phosphorylation sites and that the casein kinase
IIa′ is the most abundant casein kinase in the testis,8 for
which the knockout model shows acrosome and other
morphological defects.20 Moreover, the existence of sev-
eral candidate genes8–10 suggests genetic heterogeneity in
human globozoospermia, which could be a reason why
we did not find other patients with a gene alteration in
SPATA16. Noteworthy as well is the fact that the hetero-
zygous mouse models show no sperm abnormalities. This
indicates that mutation carriers should have normal fer-
tility. In this family, this seems to be the case, since the
father and two heterozygous brothers have fathered 10,
7, and 6 children, respectively. In two of the affected
brothers, ICSI was performed to induce fertilization and
pregnancy, but without success. This is in accordance with
the literature, which shows that ICSI enables oocyte fer-
tilization, but with low fertilization rates in about half of
the cases.
Since male infertility does not respect the canonical rule
of genetics, the determination of inheritance patterns and
the elucidation of genetic causes are complicated. Several
genetic factors have been described that affect male fer-
tility,21 but these give rise to more complex phenotypes.
However, the patients in this study did not show any men-
tal or physical abnormalities—in particular, no andro-
logical abnormalities—in addition to their aberrant semen
analysis. Thus, the mutation in SPATA16 that we found in
this study appears to present a human gene in which mu-
tations give rise to male infertility without any associated
other anomalies.
Further studies of other patients may help to identify
other participant genes involved of the formation of the
acrosome, allowing the fine dissection of the mechanisms
involved in the setup of such a specialized cellular organ-
elle. SPATA16 defects influence spermiogenesis, whereas
meiosis is not disturbed. Thus, modulation of SPATA16
function or that of other components in the same path-
way could offer an innovative, reversible approach to male
contraception that is not based on controlling the hor-
monal pathway of sperm production.
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Table 5. Polymorphisms
Patient(s), Type of
Globozoospermia,
and Variation Exon
Known
SNP
Segregation in
EthnicityParents Siblings
1:
Partial:
c.232GrA (p.E78K) 2 Yes … … European
c.397ArG (p.M133V) 2 Yes … … European
2:
Partial:
c.232GrA (p.E78K) 2 Yes … … European
c.397ArG (p.M133V) 2 Yes … … European
c.1526CrT (p.A509V) 10 No Mother Absent in
affected
brother
European
c.1577TrC (p.M526T) 10 No Mother Absent in
affected
brother
European
3 and 4:
Partial:
c.232GrA (p.E78K) 2 Yes … … European
c.397ArG (p.M133V) 2 Yes … … European
5:
Partial:
c.232GrA (p.E78K) 2 Yes … Absent in
affected
brother
North African
c.397ArG (p.M133V) 2 Yes … … …
c.440GrA (p.G147E) 2 Yes … … …
7 and 8:
Partial:
c.232GrA (p.E78K) 2 Yes … Patients are
brothers
European
c.397ArG (p.M133V) 2 Yes … … …
c.440GrA (p.G147E) 2 Yes … … …
9:
Total:
c.397ArG (p.M133V) 2 Yes … … European
10:
Total:
c.232GrA (p.E78K) 2 Yes … … North African
c.397ArG (p.M133V) 2 Yes … … …
c.440GrA (p.G147E) 2 Yes … … …
NOTE.—All nonsynonymous coding variations that were found (in 9 of 28 patients) are
shown. Three known SNPs were identified, located next to two unknown but nonsegregating
variations. In patients 6 and 11–28, no nonsynonymous coding variations were identified
(dbSNP database).
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